OXB Market Share Analysis for May 2026

OXB are already collaborating with some of the world’s most innovative medical organisations towards a shared mission.

Health > Biotechnology and Pharmaceuticals

Domainoxb.com

Year Founded1995

Employees501 - 1000

Annual Revenue$200M - $500M

OXB

OXB (including company regionals)

oxb.com

See more website traffic and engagement information

OXB Revenue up to May 2026 is 200M - 500M

revenue generated by OXB top domains

OXB top domains revenue over 3 years

Revenue for OXB top domains

oxb.com200M - 500M

See more with Sales Intelligence

Total visits to OXB's top domains

Understand OXB market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

oxb.com19.2K

See more with Sales Intelligence

Avg. visit duration in OXB's top domains

Analyze OXB engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

oxb.com00:00:24

See more with Sales Intelligence

Avg. pageviews on OXB's top domains

See how OXB keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

oxb.com1.77

See more with Sales Intelligence

OXB top competitors by domain

Top similar sites in May 2026, ranked by their affinity

chiesi.comCompany NameCHIESIEmployees5001 - 10000HQItaly, parmaAnnual revenue> $1BTotal visits157.4KHealth > Biotechnology and Pharmaceuticals

Top technologies used by OXB

These are the website technologies, by industry, used by OXB top domains

Widget (5)

reCAPTCHA

Email Services (4)

Microsoft Exchange Online

Advertising (3)

DoubleClick

Audio Video Media (3)

YouTube

More Technologies

11

See all

News & Signals from OXB

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsOxford Biomedica PLC attended event Capital Markets Event on Jun 2nd '26.Oxford, UK - 2 June 2026: OXB (LSE: OXB), a global quality and innovation-led cell and gene therapy CDMO, will today host a Capital Markets Event for equity research analysts and institutional investors at the London Stock Exchange Group (LSEG) offices, 10 Paternoster Square, EC4M 7LS, and online.

NewsOxford Biomedica PLC recognized as winner in the 'Cell & Gene Therapy - Global' category at CDMO Leadership Awards on Jul 1st '25.This latest recognition follows OXB's previous success at the CDMO Leadership Awards in 2025, when the Company was named a winner in the 'Cell & Gene Therapy - Global' category, and later recognised as a Champion in the 'Cell & Gene Therapy' category at the CDMO Leadership Awards Europe.